Fatty acid oxidation disorders.
Level 5 - mechanism / opinion, no new human data
Narrative clinical review without systematic search or original data
PubMed 30740404 · doi:10.21037/atm.2018.10.57
What was done
Narrative review describing the pathogenesis, age-dependent clinical presentations, and standard management approaches for fatty acid oxidation disorders affecting mitochondrial beta-oxidation and carnitine transport.
What was found
No quantitative data or metrics are reported in the abstract. The review describes typical presentations across the lifespan: cardiomyopathy in the neonatal period, liver dysfunction and hypoketotic hypoglycemia during infancy and childhood, and episodic rhabdomyolysis during or after adolescence. General management consists of avoiding fasting, aggressive intervention during intercurrent illness, and carnitine supplementation when indicated. Long-chain disorders require dietary fat restriction with medium-chain triglyceride oil and docosahexaenoic acid supplementation.
Why it matters
Provides an overview of clinical features and dietary management for rare inborn errors of metabolism, highlighting how early detection through newborn screening can improve clinical outcomes.
Limits
As a narrative review, it provides expert overview rather than original data, quantitative outcome metrics, or a systematic synthesis. The abstract notes an absence of and need for randomized controlled therapeutic trials.
Cited by
- supports Primary or secondary carnitine deficiency manifests clinically with elevated triglycerides and hypoketonemia due to impaired fatty acid metabolism.